The last plenary session of Congress before the summer recess took place in an extraordinary session that spotlighted the ongoing legislative process surrounding the creation of the State Agency for Public Health (AESAP). A significant topic of discussion centered on the six amendments proposed by the PP (Popular Party) that were incorporated into the original bill, which aims to modify the Law 33/2011 on General Public Health. The bill’s full text is pending publication in the Official State Gazette (BOE), and currently, only three out of the six amendments are incorporated.
Key amendments discussed in this session included a significant emotional charge, especially among the political factions present. The amendments that received approval from the lower house were noteworthy and indicated a shift in legislative cooperation. Firstly, the proposal regarding the appointment of the head of the AESAP’s Directorate passed with the backing of 142 votes in favor, 50 against, and 157 abstentions. This amendment includes a stipulation that the proposal for the director’s appointment must be evaluated by the Plenary of the Interterritorial Council of the National Health System.
The second amendment introduced additional regulations concerning the collaboration between the pharmaceutical sector and health products during health emergencies. This amendment garnered widespread support, securing 298 votes in favor, 50 against, and 1 abstention. This indicates a growing recognition of the need for coordinated efforts between the health sector and pharmaceuticals in times of crisis.
The third significant amendment pertained to the exemption or adjustment of the reference price for certain medications. This provision achieved 146 votes in favor, 51 against, and 152 abstentions. The text specifies that decisions regarding the exemption for a medication from the reference price system will be made within the Interministerial Commission for Medicines Pricing, which includes participation from autonomous communities.
Before the vote, Carmen Martínez Ramírez, a deputy from the Socialist Parliamentary Group, articulated the importance of this law, emphasizing that it has been “widely debated and agreed upon by nearly all groups within this Chamber”. She detailed how various political interests have influenced the final touches of the amendments, reinforcing a collaborative framework that respects the separate competencies of each political entity involved.
Martínez Ramírez also mentioned two amendments from the PP focused on provisions regarding veterinary medications, arguing that these should not be subject to the same regulations. Despite this, she clarified that the law still allows negotiation opportunities for the veterinary sector to present some of their claims—something that seemed unwelcoming to the PP, who had previously met with representatives but announced a disassociation from their requests.
In terms of responsiveness, the discussion also highlighted agreed modifications surrounding the establishment of state and regional response plans, ensuring a level of interoperability among different health responses. The bill pushes to incorporate incremental innovations to facilitate improvements in the pricing of strategic medications, aiding those patients who require advanced medical solutions.
Moreover, the governance structure of AESAP was under scrutiny. Martínez Ramírez indicated that since the initial processing of the law, a framework emphasizing technical independence has been meticulously crafted. The Fifth Final Provision specifically regulates the agency’s statute and reflects the importance of involving autonomous communities in its governance, alleviating PP concerns about their representation.
Rosa María Romero, a senator from the Popular Parliamentary Group, expressed that although the Interministerial Commission involves autonomous communities, its representation does not meet their desired expectations. She voiced that they require a more permanent role given that the financial responsibility for medications significantly affects their management.
Martínez Ramírez rebuffed claims that the amendments were unnecessary, affirming that autonomous communities are already well-represented within the governing council. She pointed out that such changes echo the political turbulence surrounding figures like Fernando Simón, a figure of contention in health policy debates.
Despite opposition from the PP, the legislative body aims to establish a legal framework for public health, as demonstrated by Elvira Velasco Morillo’s acknowledgment that the party is in favor of creating this agency. However, she cautioned against turning it into “a Government beach bar, away from valid scientific standards.”
The dynamic surrounding the AESAP demonstrates not only the complexities of legislative processes but also the volatility of political alliances within the Spanish Parliament. With public health on the forefront of political discussions, the interplay between parties continues to shape the evolution of health policy, setting a precedent for future legislation. The ongoing negotiations and amendments shed light on the intricacies of crafting laws that balance public interest with political strategy.